Literature DB >> 32303283

Pathophysiology of AKI to CKD progression.

Yuki Sato1, Masahiro Takahashi2, Motoko Yanagita3.   

Abstract

Acute kidney injury (AKI), defined as a rapid decrease in glomerular filtration rate, is a common and devastating pathologic condition. AKI is associated with significant morbidity and subsequent chronic kidney disease (CKD) development. Regardless of the initial insult, CKD progression after AKI involves multiple types of cells, including proximal tubular cells, fibroblasts, and immune cells. Although the mechanisms underlying this AKI to CKD progression have been investigated extensively over the past decade, therapeutic strategies still are lacking. One of the reasons for this stems from the fact that AKI and its progression toward CKD is multifactorial and variable because it is dependent on patient background. In this review, we describe the current understanding of AKI and its maladaptive repair with a focus on proximal tubules and resident fibroblasts. Subsequently, we discuss the unique pathophysiology of AKI in the elderly, highlighting our recent finding of age-dependent tertiary lymphoid tissues.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; chronic inflammation; fibroblast; proximal tubule; tertiary lymphoid tissues

Mesh:

Year:  2020        PMID: 32303283     DOI: 10.1016/j.semnephrol.2020.01.011

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  22 in total

1.  Global Perspectives in Acute Kidney Injury: Japan.

Authors:  Hiroyuki Yamada; Motoko Yanagita
Journal:  Kidney360       Date:  2022-03-29

2.  The IRE1/JNK signaling pathway regulates inflammation cytokines and production of glomerular extracellular matrix in the acute kidney injury to chronic kidney disease transition.

Authors:  Yan Liang; Lingyun Qu; Zhenjie Liu; Lulu Liang; Yingzi Wang; Songxia Quan; Yulin Wang; Lin Tang
Journal:  Mol Biol Rep       Date:  2022-06-13       Impact factor: 2.742

Review 3.  The Intersection of Acute Kidney Injury and Non-Coding RNAs: Inflammation.

Authors:  Bojun Li; Fangyou Lin; Yuqi Xia; Zehua Ye; Xinzhou Yan; Baofeng Song; Tianhui Yuan; Lei Li; Xiangjun Zhou; Weimin Yu; Fan Cheng
Journal:  Front Physiol       Date:  2022-06-09       Impact factor: 4.755

Review 4.  The role of metabolic reprogramming in tubular epithelial cells during the progression of acute kidney injury.

Authors:  Zhenzhen Li; Shan Lu; Xiaobing Li
Journal:  Cell Mol Life Sci       Date:  2021-06-29       Impact factor: 9.261

5.  Spatiotemporal ATP Dynamics during AKI Predict Renal Prognosis.

Authors:  Shinya Yamamoto; Masamichi Yamamoto; Jin Nakamura; Akiko Mii; Shigenori Yamamoto; Masahiro Takahashi; Keiichi Kaneko; Eiichiro Uchino; Yuki Sato; Shingo Fukuma; Hiromi Imamura; Michiyuki Matsuda; Motoko Yanagita
Journal:  J Am Soc Nephrol       Date:  2020-10-12       Impact factor: 10.121

6.  Survey of Current Practices of Outpatient Hemodialysis for AKI Patients.

Authors:  Victor Ortiz-Soriano; Catherine R Butler; Marla Levy; Sarah C Huen; Jorge L Castaneda; Ankit Sakhuja; Rajit K Basu; Kathleen D Liu; Jorge Cerda; Javier A Neyra
Journal:  Kidney Int Rep       Date:  2021-01-28

Review 7.  Cellular senescence and acute kidney injury.

Authors:  Xiaoxi Lin; Heng Jin; Yanfen Chai; Songtao Shou
Journal:  Pediatr Nephrol       Date:  2022-03-26       Impact factor: 3.651

Review 8.  HIF in Nephrotoxicity during Cisplatin Chemotherapy: Regulation, Function and Therapeutic Potential.

Authors:  Siyao Li; Lu Wen; Xiaoru Hu; Qingqing Wei; Zheng Dong
Journal:  Cancers (Basel)       Date:  2021-01-07       Impact factor: 6.639

Review 9.  Role of TRPA1 in Tissue Damage and Kidney Disease.

Authors:  Chung-Kuan Wu; Ji-Fan Lin; Tzong-Shyuan Lee; Yu Ru Kou; Der-Cherng Tarng
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

10.  An acute phase protein α1-acid glycoprotein mitigates AKI and its progression to CKD through its anti-inflammatory action.

Authors:  Hiroshi Watanabe; Rui Fujimura; Yuto Hiramoto; Ryota Murata; Kento Nishida; Jing Bi; Tadashi Imafuku; Hisakazu Komori; Hitoshi Maeda; Ayumi Mukunoki; Toru Takeo; Naomi Nakagata; Motoko Tanaka; Kazutaka Matsushita; Masafumi Fukagawa; Toru Maruyama
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.